Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis
Part of paid clinical trials in Weston, Florida.
- Sponsor
- The Cleveland Clinic
- Study ID
- NCT04990128
- Phase
- PHASE3
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Aspire Needle + Emcyte PureBMC — COMBINATION_PRODUCTThe Aspire Needle will be utilized to extract the bone marrow and the Emcyte PureBMC will be used to concentrate bone marrow aspirate. The final concentrate will be injected into the hip.
- Triamcinolone — DRUG40 mg (1 mL) triamcinolone and 4 cc of lidocaine 1% that will be injected into the hip.
Study Details
This is a single site, randomized single blinded, two arm study researching the effects of bone marrow aspirate concentrate (BMAC) versus Triamcinolone in patients with hip osteoarthritis. The aims and hypothesis are as follows: Specific Aim 1: Evaluate the change in pain and functional scores of a single bone marrow aspirate injection in comparison to triamcinolone in patients with hip osteoarthritis through validated patient reported outcomes scores at baseline to 12 months (6 weeks, 3 months, 6 months, and 12 months). Hypothesis: The investigators hypothesize that triamcinolone and BMAC groups will have pain reduction after each respective intervention. The changes with triamcinolone will be noticeable on the short term. The BMAC changes will take longer to have an effect but will longer duration. The investigators hypothesize that at 6 months and 1 year participants receiving BMAC will have better scores reported on the WOMAC compared to the triamcinolone injection and better than prior to injection. Specific Aim 2: Evaluate the change of bone marrow aspirate injection in comparison to triamcinolone in participant's performance on the 6 minute walk test from baseline to 12 months (6 weeks, 3 months, 6 months, and 12 months). Hypothesis: The investigators hypothesize that there will be higher walking distances on the 6 minute walk test in the participants receiving a BMAC injection in comparison to triamcinolone starting at the 3 months follow-up time. Specific Aim 3: Quantify and correlate cell characterization with patient reported outcomes score. Hypothesis: The investigators hypothesize that there will be better patient reported outcomes in patients who have a higher concentration of mesenchymal stem cells injected. The investigators will enroll 50 patients into each arm. Bone marrow will be aspirated then subsequently concentrated using the Emcyte PureBMC kit. The investigators will test the BMAC viability, rapid sterility, platelet concentration, volume, and total nucleated cell counts prior to injecting. The BMAC will be utilized as a hip injection into the affected hip of the patient. Patients receiving the Triamcinolone will undergo a sham bone needling to simulate the aspiration to keep patients blinded. Both groups will receive their injections under ultrasound guidance.
Key Dates
- Start date
- Jun 23, 2026
- Status verified
- Jun 2026
- Primary completion
- Jul 31, 2027
- Completion
- Nov 30, 2027
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Bone marrow aspirate concentrateBone marrow that is aspirated then concentrated using a device.
- Active Comparator: TriamcinoloneTriamcinolone is a corticosteroid.
Primary Outcome Measure
Western Ontario McMaster Universities Arthritis Index (WOMAC) [ Time Frame: Evaluate the change in pain and functional scores of a single bone marrow aspirate injection in comparison to triamcinolone in patients with hip osteoarthritis through validated patient reported outcomes scores at baseline to 6 weeks. ]
Central Contacts
- LEONARDO P OLIVEIRA, MD(954)659-5430
- Zoe Healy, MS(954)659-6152
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cleveland Clinic Florida | Weston | Florida | 33331 |
Find similar trials in Weston, FL
Related Studies
- General vs Spinal in Total Joint Arthroplasty (TJA)Recruiting · University of Miami · Miami, Florida
- Alexis Retractor in Total Hip ArthroplastyNot Yet Recruiting · University of Miami · Miami, Florida
- Psychosocial Interventions for Young Adults With Hip PainNot Yet Recruiting · Michael C Willey · Iowa City, Iowa
- The Pericapsular Nerve Block in Total Hip ArthroplastyPHASE4 · Recruiting · LifeBridge Health · Baltimore, Maryland